SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-161662
Filing Date
2024-06-14
Accepted
2024-06-14 16:30:58
Documents
19
Period of Report
2024-06-14
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d828399d8k.htm   iXBRL 8-K 33136
2 EX-1.1 d828399dex11.htm EX-1.1 233028
3 EX-5.1 d828399dex51.htm EX-5.1 65301
4 EX-99.1 d828399dex991.htm EX-99.1 12457
9 GRAPHIC g828399dsp001b.jpg GRAPHIC 3238
10 GRAPHIC g828399page001.jpg GRAPHIC 2760
  Complete submission text file 0001193125-24-161662.txt   608273

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA mreo-20240614.xsd EX-101.SCH 3556
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mreo-20240614_def.xml EX-101.DEF 14947
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE mreo-20240614_lab.xml EX-101.LAB 24641
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mreo-20240614_pre.xml EX-101.PRE 15915
22 EXTRACTED XBRL INSTANCE DOCUMENT d828399d8k_htm.xml XML 6143
Mailing Address ONE CAVENDISH PLACE FOURTH FLOOR LONDON X0 W1G0QF
Business Address ONE CAVENDISH PLACE FOURTH FLOOR LONDON X0 W1G0QF 4403330237300
Mereo BioPharma Group plc (Filer) CIK: 0001719714 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38452 | Film No.: 241045356
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)